Equasens S.A.
Equasens S.A. (PAR: EQS) is trading at €33.10, about ₹3,616 at today's EUR/INR rate, as of 28 Sep 2026, 11:35 AM ET, up 12.39% today. Indian residents can buy Equasens from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€31.70
Today's high
€34.35
52 week low
€28.60
52 week high
€45.35
EQS opened at €31.80, closed previously at €29.45, and has traded between €28.60 and €45.35 over the past 52 weeks.
About
Equasens S.A., established in 1996 and headquartered in Villers-les-Nancy, France, delivers a diverse portfolio of information technology solutions tailored for the European healthcare industry. The company primarily equips pharmacies and their networks with advanced management systems, including LGPI global services and OffiCentral. Pharmacists leverage a comprehensive suite of tools designed to streamline daily business operations, such as OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker. To foster stronger customer relationships and engagement, Equasens provides innovative solutions like OffiTag, OffiTouch, OffiMédia, OffiConnect, alongside automation systems and loyalty program management. Beyond operational software, the company offers analytical insights through its My Pilot tool and professional development opportunities via OffiLearning, an e-learning platform. A key area of focus is patient support, with offerings spanning compliance monitoring software, Multimeds, Automeds, OffiTéléconsult, and essential pharmaceutical and shared medical record services. The company's specialized systems include ULTIMATE, which combines efficient pharmacy administration with enhanced patient care, and FARMACLICK, a protocol facilitating communication between pharmacies and wholesale distributors (the latter also served by DIFARM). Additional retail management tools comprise PHARE and the SOPHIA pharmacy application, complemented by OffiMédia POS displays. Equasens also addresses specific health needs, such as chronic renal failure management with eNephro, and simplifies the administration of patient education programs through TPE Pilot. Further extending its reach across the healthcare sector, Equasens offers various dedicated solutions like NOVIACARE, CARELIB (for home and nursing home care), KAPELSE, TITAN, ANTHADINE software, the MOBISOINS mobile tool, MICROSOINS for in-home nursing care, and LOGICLIC. For holistic patient journey oversight, the AXIGATE solutions and CHORUS platform are available. Supplementary services include medical telesecretarial assistance for healthcare professionals and equipment lease financing options. Equasens S.A. functions as a subsidiary of Marque Verte Sante.
Key statistics
Avg. volume
15.37K
Market cap
€497.57M
P/E Ratio
12.78
Price-to-sales ratio
2.10
Enterprise value
€517.25M
Free cash flow yield
11.82%
Debt-to-equity ratio
0.21
Return on equity
16.31%
ROIC
11.18%
Beta
0.56
Dividend yield
4.23%
Last dividend
€1.40
Financial overview
Revenue
€236.52M
Earnings per share
€2.73
Free cash flow
€47.10M
Net profit margin
16.63%
Gross margin
21.03%
EBITDA
€65.30M
Revenue growth
9.12%
Similar securities
This is not an investment recommendation
How to buy Equasens from India
Indian residents can buy Equasens shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Equasens and place an order
Find Equasens by name or by its ticker, EQS, and choose an order type. Equasens trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Equasens position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Equasens from India
Trading and taxes when buying Equasens from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Equasens’ current yield is 4.23%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Equasens stock?
Yes. Equasens (EQS) has been listed on Euronext Paris since 2000, in the Software - Application industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Equasens share cost in rupees?
One Equasens share is €33.10 — about ₹3,616 at an EUR/INR rate of 109.26 on 27 Sep 2026. Both the Equasens price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Equasens from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Equasens shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Equasens price. Paasa issues a capital-gains statement for your return.
Does Equasens pay a dividend, and how is it taxed in India?
Yes. Equasens pays a dividend and the current yield is 4.23%; the last declared dividend was €1.40 per share, about ₹152.96. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Equasens from India?
Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.
Do I have to declare Equasens shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Equasens holding, its cost and its closing value.
How do I sell Equasens and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Equasens?
Yes. Equasens is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.